My laboratory works at the interface between preclinical and clinical imaging and therapy. On our team, basic scientists (such as physicists, engineers, biologists, geneticists, and chemists) work in concert with oncologists and radiologists toward one common goal: the translation of novel drugs, imaging agents, and methodologies from bench to bedside for the benefit of clinical cancer care.
Wolfgang A. Weber, MD
Chief, Molecular Imaging and Therapy Service
Research FocusPhysician-scientist Wolfgang Weber specializes in imaging and therapy, with a focus on the translation of novel drugs, imaging agents, and methodologies from bench to bedside.
- Dumont RA, Tamma M, Braun F, Borkowski S, Reubi JC, Maecke H, Weber WA, Mansi R (2013) Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin. Journal of Nuclear Medicine. Epub ahead of print.
- Leonhardt F, Grundmann S, Behe M, Bluhm F, Dumont RA, Braun F, Fani M, Riesner K, Prinz G, Hechinger A-K et al. (2013) Inflammatory neovascularization during graft-versus-host disease is regulated by alphav integrin and miR-100. Blood 121:3307–3318.